个人简介：

中山大学附属第七医院研究员，中山大学附属第七医院流行病与统计学教研室主任，中山大学附属第七医院临床研究中心副主任，中山大学附属第七医院临床医学大数据中心副主任，伯明翰大学中山七院联合临床研究所副所长，广东省消化道恶性肿瘤防治工程技术中心副主任。深圳市海外高层次海外留学人才，伯明翰大学Vanguard学者，广东省预防医学会流行病学专委会青年委员会常委，中国控烟协会理事；主要从事胃酸分泌减少的健康影响及生物医学大数据相关研究。累积发表SCI论文153篇，其中以第一作者/通讯作者累积在Gastroenterology、Gut、Nature communications、Eur Urol、等杂志发表论文55篇，累积引用次数>4300次, H-index = 38；执笔3部国家指南《中国消化外科抑酸药物规范化使用的临床实践指南（2022版）》、《中国人群胃癌风险管理公众指南（2023版）》、《中国人群骨质疏松风险管理公众指南（2024版）》；主持国自然青年/面上项目、Wellcome Leap临床基金子项目等多项基金；任Therapeutic Advances in Medical Oncology统计编辑。

教育背景：

1. 2013.09–2017.11 香港中文大学，公共卫生及基层医疗学院流行病学系，流行病学博士

2. 2015.09–2016.01 布里斯托大学，社会和社区医学学院统计学系，访问博士

3. 2011.09–2012.08 香港中文大学，公共卫生及基层医疗学院流行病学系，公共卫生硕士

4. 2006.09–2011.06 兰州大学，第一临床医学院，临床医学学士

研究工作经历：

1. 2025.1 - 至今: 研究员，中山大学附属第七医院，科研中心

2. 2019.2 - 2024.12: 副研究员，中山大学附属第七医院，科研中心

3. 2018.01–2019.01 博士后, 香港中文大学, 公共卫生及基层医疗学院流行病学系

4. 2012.10 - 2013.08: 研究助理，香港中文大学，公共卫生及基层医疗学院流行病学系

研究方向：

1. 胃酸分泌减少的健康影响

2. 生物医学大数据

3. 循证医疗决策

代表性论文：

1. Xia B, He Q, Smith FG, Gkoutos VG, Nirantharakumar K, Kuo ZC, Wang D, Feng Q, Cheung EC, Dai L, Huang J, Yu Y, Meng W*, Qin X*, Yuan J*. Individualized prevention of proton pump inhibitor related adverse events by risk stratification. Nat Commun. 2024 Apr 27;15(1):3591. (IF: 14.1)

2. Li W, Zhou Y, Luo Z, Tang R, Sun Y, He Q, Xia B, Lu K, Hou Q, Yuan J*. Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer's disease. FASEB J. 2023 Jul;37(7):e22998. (IF: 5.843) 

3. Zhang X, Yue P, Zhang J, Yang M, Chen J, Zhang B, Luo W, Wang M, Da Z, Lin Y, Zhou W, Zhang L, Zhu K, Ren Y, Yang L, Li S*, Yuan J*, Meng W*, Leung JW, Li X. A novel machine learning model and a public online prediction platform for prediction of post-ERCP-cholecystitis (PEC). EClinicalMedicine. 2022 May 13;48:101431.. (IF: 17.033)

4. Yang M, He Q, Gao F, Nirantharakumar K, Veenith T, Qin X, Page AT, Wong MCS, Huang J, Kuo ZC, Xia B, Zhang C, He Y, Meng W*, Yuan J*, Pan Y*. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials. BMC Med. 2021 Dec 3;19(1):316. (IF: 11.15)

5. Xia B, Yang M, Nguyen LH, He Q, Zhen J, Yu Y, Di M, Qin X, Lu K, Kuo ZC, He Y, Zhang C, Meng W, Yuan J*. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts. Gastroenterology. 2021 Dec;161(6):1842-1852 (IF: 33.883)

6. He Q, Xia B, Meng W, Fan D, Kuo ZC, Huang J, Qin X, Zou H, He Y, Zhang C, Fang S, Pan Y, Yang M, Yuan J*. No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants. Am J Gastroenterol. 2021 Nov 1;116(11):2286-2291. (IF:12.045)

7. Jinqiu Yuan, Qiangsheng He, Long H Nguyen, et al. Regular use of proton pump inhibitor and risk of type 2 diabetes: results from three prospective cohort studies. Gut. 2021 Jun;70(6):1070-1077. (IF: 31.793)

8. Qiangsheng He, Man Yang, Xiwen Qin, Die Fan, Jinqiu Yuan*, Yihang Pan*. Risk stratification for proton pump inhibitor-associated type 2 diabetes: a population-based cohort study. Gut. 2021 Nov;70(11):2212-2213 (IF: 31.793)

9. Jinqiu Yuan, Yanhong Jessika Hu, Jie Zheng, et al. Long-term use of antibiotics and risk of type 2 diabetes in women: a prospective cohort study. Int J Epidemiol. 2020 Oct 1;49(5):1572-1581. doi: 10.1093/ije/dyaa122.（IF: 9.685）

10. Jinqiu Yuan, Changhua Zhang, Jeffrey A, et al. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study. Aliment Pharmacol Ther 2020;52: 449-458.（IF=9.524）

11. Bin Xia, Qiang-Sheng He, Fang Gao, An-Ran Liu, Yan Tang, Charing Chong, Anthony Y. B. Teoh, Fang-Ping Li, Yi-Hang Pan, Yu-Long He*, Chang-Hua Zhang*, Jin-Qiu Yuan*. Metabolic Syndrome and Risk of Pancreatic Cancer: A population-based prospective cohort study. Int J Cancer. 2020 Dec 15;147(12):3384-3393（IF: 7.316）

12. Yuan JQ, Tsoi KK, Yang M, Wang JY, Threapleton DE, Yang ZY, Zou B, Mao C, Tang JL, Chan FK. Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity. Aliment Pharmacol Ther 2016;43(12): 1262-75（IF=9.524）

13. Wang H, Yuan J, Zhang B, Dong M, Mao C, Hu D. Phototherapy for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2015; 11: No.: CD011979 (IF: 6.103)

14. Yuan JQ, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J. Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis. Eur Urol 2013; 63(5): 902-12. (IF: 24.267)

15.  Yuan JQ, Mao C, Tang JL. Prevalence of risk factors for non-communicable diseases in prison populations. Lancet 2012; 380(9849): 1227. (IF: 44.002) 

联系方式：

课题组长期招收流行病统计学、生物信息学、大数据人工智能相关助理/实习研究员及博士后，有申请意愿欢迎邮件联系（yuanjq5@mail.sysu.edu.cn）